Registration
FOLEY HOAG LLP for OREXIGEN THERAPEUTICS, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislative and regulatory matters related to the Food and Drug Administration (FDA) with a focus on the regulation of novel therapeutics for the treatment of obesity.
| Lobbyist | Covered position, as disclosed |
|---|---|
| - New | Waxman counsel; Senator Pryor staff |
| J KEVIN BRENNAN New | — |
| RODGER CURRIE New | — |
| PAUL KIM New | Senator Kennedy Director For Health Policy; Congressman |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.